Papillary thyroid carcinoma: Factors influencing recurrence and survival

Annals of Surgical Oncology

Volumn 15, Issue 5, 2008, Pages 1518-1522

  Toniato, Antonio ^a   Boschin, Isabella ^a   Casara, Dario ^b   Mazzarotto, Renzo ^b   Rubello, Domenico ^b   Pelizzo, Mariarosa ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Papillary thyroid carcinoma; Recurrence; Survival

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THYROTROPIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PROGNOSIS; SEX DIFFERENCE; SURVIVAL RATE; THYROID CARCINOMA; THYROID SURGERY; THYROIDECTOMY; TUMOR VOLUME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 41549162818     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9859-4     Document Type: Article

References (22)

1. Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001; 86:1447-63
2. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Eng J Med 1998; 338:297-306
3. Kjellman P, Zedenius J, Lundell G, et al. Predictors of outcome in patients with papillary thyroid carcinoma. Eur J Surg Oncol 2006; 32:345-52
4. Pelizzo MR, Toniato A, Grigoletto R. Surgical treatment of papillary thyroid carcinoma: uni and multivariate analysis of prognostic factors (TNM staging system included). J Exp Clin Cancer Res 1997; 16:261-5
5. Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005; 90:5723-29
6. Pelizzo MR, Toniato A, Boschin IM, et al. Locally advanced differentiated thyroid carcinoma: a 35 year mono institutional experience in 280 patients. Nucl Med Commun 2005; 26:965-8
7. Voutilainen PE, Siironen P, Franssila KO, et al. AMES, MACIS and TNM prognostic classification in papillary thyroid carcinoma. Anticancer Res 2003; 23:4283-88
8. Pasieka JL, Zedenius J, Auer G, et al. Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 1992; 112:1154-9
9. Hay ID, Pergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114:1050-57
10. Van Nguyen K, Dilawari RA. Predictive value of AMES scoring system in selection of extent of surgery in well differentiated carcinoma of thyroid. Am Surg 1995; 61:151-55
11. Jukkola A, Bloigu R, Ebeling T, et al. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 2004; 11:571-79
12. Lang B, Lo C, Chan W, et al. Staging systems for papillary thyroid carcinoma. A review and comparison. Ann Surg 2007; 245:366-78
13. Sobin LH, Wittekind C. UICC: TNM Classification of Malignant Tumors, 6th edn. New York:, Wiley-Liss, 2002
14. Byar D, Green S, Dor P, et al. A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid cancer cooperative group. Eur. J Cancer 1979; 15:472-9
15. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988; 104:947-53
16. Voutilainen P, Shronen P, Franssila K, et al. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma. Anticancer Res 2003; 23:4283-8
17. DeGroot L, Kaplan E, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71:414-24
18. Dean DS, Hay ID. Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 2000; 7:229-39
19. Shaha JP, Loree TR, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992; 164:658-61
20. Ito Y, Miyauchi A, Jikuzono T, et al.: Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification stage grouping. World J Surg 2007; 31:838-48
21. Mazzaferri EL, Jhiang SM. Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97:418-28
22. Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002; 26:879-85